Min Li, Ph.D.

US Food and Drug Administration

Poster(s):

• (T1530-08-54) Critical Formulation Attributes of Naloxone Nasal Spray Products Affecting Nasal Permeation
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (W1230-10-67) Development of In Vitro In Vivo Correlation for Establishing Clinically Relevant Dissolution Specifications of Lamotrigine ER Tablets
  Wednesday, October 25, 2023

  12:30 PM – 1:30 PM ET